Esperion Therapeutics, Inc. (ESPR) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ESPR. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 184 institutions reported holding ESPR, with 204.9 million shares worth $645.8 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Glazer Capital | 22,416,339 | $71M | NEW |
| BlackRock | 22,128,021 | $70M | INCREASED |
| Vanguard | 15,744,764 | $50M | INCREASED |
| Trium Capital | 11,158,150 | $35M | NEW |
| Goldman Sachs | 10,380,646 | $33M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Esperion Therapeutics, Inc. on SentiSense.